Facebook
Google+
LinkedIn
Centrose, LLC - developer of biopharmaceutical drugs specializing in CarboConnect, a molecule drug compounds based on sugar chemistry that will enhance the speed and efficiency at which targeted drugs can be made better by sugar attachments.
Company Information
Est. Revenue: $5 Million
Employees: 10
The contact, business and financial information provided above regarding Centrose, LLC is believed to be factual and up-to-date, but BB101 does not guarantee its accuracy. In some cases, estimated revenue has been calculated based on employee count and industry statistics. The information on these manufacturers and service companies may have changed recently so please contact the business itself for further information and data. More Companies to Explore